Epithelial-Mesenchymal Transition, human (Scheel, 2011): : averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXK1
|
ENSG00000164916.9 | FOXK1 |
FOXP2
|
ENSG00000128573.18 | FOXP2 |
FOXB1
|
ENSG00000171956.5 | FOXB1 |
FOXP3
|
ENSG00000049768.10 | FOXP3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXK1 | hg19_v2_chr7_+_4721885_4721945 | 0.64 | 8.5e-02 | Click! |
FOXP3 | hg19_v2_chrX_-_49121165_49121288 | 0.46 | 2.6e-01 | Click! |
FOXP2 | hg19_v2_chr7_+_114055052_114055378 | 0.20 | 6.4e-01 | Click! |
FOXB1 | hg19_v2_chr15_+_60296421_60296464 | 0.01 | 9.8e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_165424973 | 2.69 |
ENST00000543549.1 |
GRB14 |
growth factor receptor-bound protein 14 |
chr11_-_108464465 | 2.01 |
ENST00000525344.1 |
EXPH5 |
exophilin 5 |
chr11_-_108464321 | 1.85 |
ENST00000265843.4 |
EXPH5 |
exophilin 5 |
chr18_+_21529811 | 1.77 |
ENST00000588004.1 |
LAMA3 |
laminin, alpha 3 |
chr8_+_95653373 | 1.72 |
ENST00000358397.5 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr8_+_95653302 | 1.70 |
ENST00000423620.2 ENST00000433389.2 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr11_+_10476851 | 1.57 |
ENST00000396553.2 |
AMPD3 |
adenosine monophosphate deaminase 3 |
chr2_+_163175394 | 1.48 |
ENST00000446271.1 ENST00000429691.2 |
GCA |
grancalcin, EF-hand calcium binding protein |
chr8_+_31497271 | 1.44 |
ENST00000520407.1 |
NRG1 |
neuregulin 1 |
chr12_-_28122980 | 1.22 |
ENST00000395868.3 ENST00000534890.1 |
PTHLH |
parathyroid hormone-like hormone |
chr12_-_28123206 | 1.14 |
ENST00000542963.1 ENST00000535992.1 |
PTHLH |
parathyroid hormone-like hormone |
chr8_-_127570603 | 1.12 |
ENST00000304916.3 |
FAM84B |
family with sequence similarity 84, member B |
chr12_-_53343602 | 1.11 |
ENST00000546897.1 ENST00000552551.1 |
KRT8 |
keratin 8 |
chr11_-_72504681 | 1.07 |
ENST00000538536.1 ENST00000543304.1 ENST00000540587.1 ENST00000334805.6 |
STARD10 |
StAR-related lipid transfer (START) domain containing 10 |
chr19_-_35992780 | 1.06 |
ENST00000593342.1 ENST00000601650.1 ENST00000408915.2 |
DMKN |
dermokine |
chr8_+_95653427 | 1.03 |
ENST00000454170.2 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr1_+_153003671 | 1.03 |
ENST00000307098.4 |
SPRR1B |
small proline-rich protein 1B |
chr11_-_115375107 | 1.03 |
ENST00000545380.1 ENST00000452722.3 ENST00000537058.1 ENST00000536727.1 ENST00000542447.2 ENST00000331581.6 |
CADM1 |
cell adhesion molecule 1 |
chr3_-_190167571 | 1.00 |
ENST00000354905.2 |
TMEM207 |
transmembrane protein 207 |
chr17_+_38333263 | 0.99 |
ENST00000456989.2 ENST00000543876.1 ENST00000544503.1 ENST00000264644.6 ENST00000538884.1 |
RAPGEFL1 |
Rap guanine nucleotide exchange factor (GEF)-like 1 |
chr10_-_45474237 | 0.98 |
ENST00000448778.1 ENST00000298295.3 |
C10orf10 |
chromosome 10 open reading frame 10 |
chr18_-_53070913 | 0.97 |
ENST00000568186.1 ENST00000564228.1 |
TCF4 |
transcription factor 4 |
chr13_-_41240717 | 0.95 |
ENST00000379561.5 |
FOXO1 |
forkhead box O1 |
chr2_-_69098566 | 0.91 |
ENST00000295379.1 |
BMP10 |
bone morphogenetic protein 10 |
chr13_-_86373536 | 0.90 |
ENST00000400286.2 |
SLITRK6 |
SLIT and NTRK-like family, member 6 |
chr2_-_113542063 | 0.90 |
ENST00000263339.3 |
IL1A |
interleukin 1, alpha |
chr5_-_16509101 | 0.90 |
ENST00000399793.2 |
FAM134B |
family with sequence similarity 134, member B |
chr12_+_20848282 | 0.89 |
ENST00000545604.1 |
SLCO1C1 |
solute carrier organic anion transporter family, member 1C1 |
chr21_-_42219065 | 0.88 |
ENST00000400454.1 |
DSCAM |
Down syndrome cell adhesion molecule |
chr12_+_20848377 | 0.88 |
ENST00000540354.1 ENST00000266509.2 ENST00000381552.1 |
SLCO1C1 |
solute carrier organic anion transporter family, member 1C1 |
chr1_+_13910194 | 0.87 |
ENST00000376057.4 ENST00000510906.1 |
PDPN |
podoplanin |
chr7_-_20256965 | 0.85 |
ENST00000400331.5 ENST00000332878.4 |
MACC1 |
metastasis associated in colon cancer 1 |
chr18_+_21452804 | 0.84 |
ENST00000269217.6 |
LAMA3 |
laminin, alpha 3 |
chr8_-_80993010 | 0.84 |
ENST00000537855.1 ENST00000520527.1 ENST00000517427.1 ENST00000448733.2 ENST00000379097.3 |
TPD52 |
tumor protein D52 |
chr4_-_74486217 | 0.82 |
ENST00000335049.5 ENST00000307439.5 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
chr10_+_111985713 | 0.81 |
ENST00000239007.7 |
MXI1 |
MAX interactor 1, dimerization protein |
chr4_-_123542224 | 0.80 |
ENST00000264497.3 |
IL21 |
interleukin 21 |
chr1_+_152486950 | 0.79 |
ENST00000368790.3 |
CRCT1 |
cysteine-rich C-terminal 1 |
chr3_+_136676707 | 0.79 |
ENST00000329582.4 |
IL20RB |
interleukin 20 receptor beta |
chr10_+_24755416 | 0.78 |
ENST00000396446.1 ENST00000396445.1 ENST00000376451.2 |
KIAA1217 |
KIAA1217 |
chr1_-_12677714 | 0.78 |
ENST00000376223.2 |
DHRS3 |
dehydrogenase/reductase (SDR family) member 3 |
chr17_-_39942940 | 0.76 |
ENST00000310706.5 ENST00000393931.3 ENST00000424457.1 ENST00000591690.1 |
JUP |
junction plakoglobin |
chr20_+_58630972 | 0.76 |
ENST00000313426.1 |
C20orf197 |
chromosome 20 open reading frame 197 |
chr1_+_24646002 | 0.75 |
ENST00000356046.2 |
GRHL3 |
grainyhead-like 3 (Drosophila) |
chr1_+_24645807 | 0.74 |
ENST00000361548.4 |
GRHL3 |
grainyhead-like 3 (Drosophila) |
chr8_+_31496809 | 0.74 |
ENST00000518104.1 ENST00000519301.1 |
NRG1 |
neuregulin 1 |
chr1_+_24645865 | 0.73 |
ENST00000342072.4 |
GRHL3 |
grainyhead-like 3 (Drosophila) |
chrX_-_117119243 | 0.72 |
ENST00000539496.1 ENST00000469946.1 |
KLHL13 |
kelch-like family member 13 |
chr12_-_28124903 | 0.71 |
ENST00000395872.1 ENST00000354417.3 ENST00000201015.4 |
PTHLH |
parathyroid hormone-like hormone |
chr13_-_46716969 | 0.71 |
ENST00000435666.2 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
chr18_-_53257027 | 0.70 |
ENST00000568740.1 ENST00000564403.2 ENST00000537578.1 |
TCF4 |
transcription factor 4 |
chr18_-_53303123 | 0.70 |
ENST00000569357.1 ENST00000565124.1 ENST00000398339.1 |
TCF4 |
transcription factor 4 |
chr10_+_118187379 | 0.69 |
ENST00000369230.3 |
PNLIPRP3 |
pancreatic lipase-related protein 3 |
chr6_-_136847099 | 0.69 |
ENST00000438100.2 |
MAP7 |
microtubule-associated protein 7 |
chr5_+_140186647 | 0.69 |
ENST00000512229.2 ENST00000356878.4 ENST00000530339.1 |
PCDHA4 |
protocadherin alpha 4 |
chr6_-_136847610 | 0.68 |
ENST00000454590.1 ENST00000432797.2 |
MAP7 |
microtubule-associated protein 7 |
chr12_-_8814669 | 0.66 |
ENST00000535411.1 ENST00000540087.1 |
MFAP5 |
microfibrillar associated protein 5 |
chr14_-_91526922 | 0.65 |
ENST00000418736.2 ENST00000261991.3 |
RPS6KA5 |
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
chr3_+_136676851 | 0.65 |
ENST00000309741.5 |
IL20RB |
interleukin 20 receptor beta |
chr14_+_21525981 | 0.64 |
ENST00000308227.2 |
RNASE8 |
ribonuclease, RNase A family, 8 |
chr2_-_161056802 | 0.62 |
ENST00000283249.2 ENST00000409872.1 |
ITGB6 |
integrin, beta 6 |
chr2_-_161056762 | 0.61 |
ENST00000428609.2 ENST00000409967.2 |
ITGB6 |
integrin, beta 6 |
chr1_-_207206092 | 0.60 |
ENST00000359470.5 ENST00000461135.2 |
C1orf116 |
chromosome 1 open reading frame 116 |
chrX_-_133792480 | 0.60 |
ENST00000359237.4 |
PLAC1 |
placenta-specific 1 |
chr1_+_209602771 | 0.59 |
ENST00000440276.1 |
MIR205HG |
MIR205 host gene (non-protein coding) |
chr2_+_47596287 | 0.59 |
ENST00000263735.4 |
EPCAM |
epithelial cell adhesion molecule |
chr5_-_115872142 | 0.58 |
ENST00000510263.1 |
SEMA6A |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr8_+_86376081 | 0.58 |
ENST00000285379.5 |
CA2 |
carbonic anhydrase II |
chr2_+_27665232 | 0.57 |
ENST00000543753.1 ENST00000288873.3 |
KRTCAP3 |
keratinocyte associated protein 3 |
chr5_+_140220769 | 0.56 |
ENST00000531613.1 ENST00000378123.3 |
PCDHA8 |
protocadherin alpha 8 |
chr8_+_99956759 | 0.56 |
ENST00000522510.1 ENST00000457907.2 |
OSR2 |
odd-skipped related transciption factor 2 |
chr20_+_58152524 | 0.56 |
ENST00000359926.3 |
PHACTR3 |
phosphatase and actin regulator 3 |
chr8_-_57233103 | 0.56 |
ENST00000303749.3 ENST00000522671.1 |
SDR16C5 |
short chain dehydrogenase/reductase family 16C, member 5 |
chr1_-_242612779 | 0.55 |
ENST00000427495.1 |
PLD5 |
phospholipase D family, member 5 |
chr2_+_27665289 | 0.55 |
ENST00000407293.1 |
KRTCAP3 |
keratinocyte associated protein 3 |
chr7_-_25702669 | 0.54 |
ENST00000446840.1 |
AC003090.1 |
AC003090.1 |
chr1_+_84630367 | 0.53 |
ENST00000370680.1 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
chrX_-_117107542 | 0.53 |
ENST00000371878.1 |
KLHL13 |
kelch-like family member 13 |
chr12_-_31479045 | 0.52 |
ENST00000539409.1 ENST00000395766.1 |
FAM60A |
family with sequence similarity 60, member A |
chr18_+_21452964 | 0.52 |
ENST00000587184.1 |
LAMA3 |
laminin, alpha 3 |
chr1_-_207095324 | 0.52 |
ENST00000530505.1 ENST00000367091.3 ENST00000442471.2 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
chr6_-_29013017 | 0.52 |
ENST00000377175.1 |
OR2W1 |
olfactory receptor, family 2, subfamily W, member 1 |
chr14_-_21567009 | 0.51 |
ENST00000556174.1 ENST00000554478.1 ENST00000553980.1 ENST00000421093.2 |
ZNF219 |
zinc finger protein 219 |
chr2_+_42104692 | 0.51 |
ENST00000398796.2 ENST00000442214.1 |
AC104654.1 |
AC104654.1 |
chr4_-_77328458 | 0.49 |
ENST00000388914.3 ENST00000434846.2 |
CCDC158 |
coiled-coil domain containing 158 |
chr1_+_220960033 | 0.49 |
ENST00000366910.5 |
MARC1 |
mitochondrial amidoxime reducing component 1 |
chrX_+_135614293 | 0.49 |
ENST00000370634.3 |
VGLL1 |
vestigial like 1 (Drosophila) |
chr14_+_61789382 | 0.49 |
ENST00000555082.1 |
PRKCH |
protein kinase C, eta |
chr7_-_121944491 | 0.48 |
ENST00000331178.4 ENST00000427185.2 ENST00000442488.2 |
FEZF1 |
FEZ family zinc finger 1 |
chr8_+_99956662 | 0.48 |
ENST00000523368.1 ENST00000297565.4 ENST00000435298.2 |
OSR2 |
odd-skipped related transciption factor 2 |
chr8_+_128748308 | 0.48 |
ENST00000377970.2 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
chrX_+_135618258 | 0.48 |
ENST00000440515.1 ENST00000456412.1 |
VGLL1 |
vestigial like 1 (Drosophila) |
chr12_-_123201337 | 0.47 |
ENST00000528880.2 |
HCAR3 |
hydroxycarboxylic acid receptor 3 |
chr11_-_72504637 | 0.46 |
ENST00000536377.1 ENST00000359373.5 |
STARD10 ARAP1 |
StAR-related lipid transfer (START) domain containing 10 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr18_+_55888767 | 0.46 |
ENST00000431212.2 ENST00000586268.1 ENST00000587190.1 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr14_+_61788429 | 0.46 |
ENST00000332981.5 |
PRKCH |
protein kinase C, eta |
chr2_-_113594279 | 0.45 |
ENST00000416750.1 ENST00000418817.1 ENST00000263341.2 |
IL1B |
interleukin 1, beta |
chr7_-_41742697 | 0.45 |
ENST00000242208.4 |
INHBA |
inhibin, beta A |
chr2_+_207804278 | 0.45 |
ENST00000272852.3 |
CPO |
carboxypeptidase O |
chr6_+_134758827 | 0.45 |
ENST00000431422.1 |
LINC01010 |
long intergenic non-protein coding RNA 1010 |
chr8_+_128748466 | 0.45 |
ENST00000524013.1 ENST00000520751.1 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
chr5_+_121465207 | 0.45 |
ENST00000296600.4 |
ZNF474 |
zinc finger protein 474 |
chr11_-_118122996 | 0.45 |
ENST00000525386.1 ENST00000527472.1 ENST00000278949.4 |
MPZL3 |
myelin protein zero-like 3 |
chr14_-_31926701 | 0.45 |
ENST00000310850.4 |
DTD2 |
D-tyrosyl-tRNA deacylase 2 (putative) |
chr12_-_28125638 | 0.44 |
ENST00000545234.1 |
PTHLH |
parathyroid hormone-like hormone |
chr2_-_69180083 | 0.44 |
ENST00000328895.4 |
GKN2 |
gastrokine 2 |
chr4_-_74486347 | 0.44 |
ENST00000342081.3 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
chr8_+_124194875 | 0.44 |
ENST00000522648.1 ENST00000276699.6 |
FAM83A |
family with sequence similarity 83, member A |
chr19_+_45844018 | 0.44 |
ENST00000585434.1 |
KLC3 |
kinesin light chain 3 |
chr18_+_61254534 | 0.43 |
ENST00000269489.5 |
SERPINB13 |
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr9_-_135996537 | 0.43 |
ENST00000372050.3 ENST00000372047.3 |
RALGDS |
ral guanine nucleotide dissociation stimulator |
chr5_+_140207536 | 0.43 |
ENST00000529310.1 ENST00000527624.1 |
PCDHA6 |
protocadherin alpha 6 |
chr7_-_37026108 | 0.43 |
ENST00000396045.3 |
ELMO1 |
engulfment and cell motility 1 |
chr14_+_96671016 | 0.43 |
ENST00000542454.2 ENST00000554311.1 ENST00000306005.3 ENST00000539359.1 ENST00000553811.1 |
BDKRB2 RP11-404P21.8 |
bradykinin receptor B2 Uncharacterized protein |
chr15_+_43886057 | 0.43 |
ENST00000441322.1 ENST00000413657.2 ENST00000453733.1 |
CKMT1B |
creatine kinase, mitochondrial 1B |
chr6_+_112375462 | 0.42 |
ENST00000361714.1 |
WISP3 |
WNT1 inducible signaling pathway protein 3 |
chr17_-_46657473 | 0.42 |
ENST00000332503.5 |
HOXB4 |
homeobox B4 |
chr7_+_30174426 | 0.41 |
ENST00000324453.8 |
C7orf41 |
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
chr17_+_26662597 | 0.41 |
ENST00000544907.2 |
TNFAIP1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr18_+_61442629 | 0.41 |
ENST00000398019.2 ENST00000540675.1 |
SERPINB7 |
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr4_-_74486109 | 0.41 |
ENST00000395777.2 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
chr12_-_31479107 | 0.41 |
ENST00000542983.1 |
FAM60A |
family with sequence similarity 60, member A |
chr6_+_32121908 | 0.40 |
ENST00000375143.2 ENST00000424499.1 |
PPT2 |
palmitoyl-protein thioesterase 2 |
chr6_-_30043539 | 0.40 |
ENST00000376751.3 ENST00000244360.6 |
RNF39 |
ring finger protein 39 |
chr7_+_129906660 | 0.40 |
ENST00000222481.4 |
CPA2 |
carboxypeptidase A2 (pancreatic) |
chr10_+_24738355 | 0.40 |
ENST00000307544.6 |
KIAA1217 |
KIAA1217 |
chr17_-_56492989 | 0.40 |
ENST00000583753.1 |
RNF43 |
ring finger protein 43 |
chr15_+_43985725 | 0.40 |
ENST00000413453.2 |
CKMT1A |
creatine kinase, mitochondrial 1A |
chr14_-_31926623 | 0.40 |
ENST00000356180.4 |
DTD2 |
D-tyrosyl-tRNA deacylase 2 (putative) |
chr3_+_189349162 | 0.39 |
ENST00000264731.3 ENST00000382063.4 ENST00000418709.2 ENST00000320472.5 ENST00000392460.3 ENST00000440651.2 |
TP63 |
tumor protein p63 |
chr6_+_32121789 | 0.39 |
ENST00000437001.2 ENST00000375137.2 |
PPT2 |
palmitoyl-protein thioesterase 2 |
chr8_-_28243934 | 0.39 |
ENST00000521185.1 ENST00000520290.1 ENST00000344423.5 |
ZNF395 |
zinc finger protein 395 |
chr10_+_123923105 | 0.39 |
ENST00000368999.1 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr3_-_111314230 | 0.39 |
ENST00000317012.4 |
ZBED2 |
zinc finger, BED-type containing 2 |
chr14_+_96722539 | 0.38 |
ENST00000553356.1 |
BDKRB1 |
bradykinin receptor B1 |
chr8_+_124194752 | 0.38 |
ENST00000318462.6 |
FAM83A |
family with sequence similarity 83, member A |
chr6_-_42418999 | 0.38 |
ENST00000340840.2 ENST00000354325.2 |
TRERF1 |
transcriptional regulating factor 1 |
chr2_-_71454185 | 0.38 |
ENST00000244221.8 |
PAIP2B |
poly(A) binding protein interacting protein 2B |
chr7_-_105332084 | 0.37 |
ENST00000472195.1 |
ATXN7L1 |
ataxin 7-like 1 |
chr7_-_140624499 | 0.36 |
ENST00000288602.6 |
BRAF |
v-raf murine sarcoma viral oncogene homolog B |
chr14_-_21493649 | 0.36 |
ENST00000553442.1 ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2 |
NDRG family member 2 |
chr19_-_16045220 | 0.36 |
ENST00000326742.8 |
CYP4F11 |
cytochrome P450, family 4, subfamily F, polypeptide 11 |
chr10_+_123922941 | 0.35 |
ENST00000360561.3 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr18_+_61254570 | 0.35 |
ENST00000344731.5 |
SERPINB13 |
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr13_+_73629107 | 0.35 |
ENST00000539231.1 |
KLF5 |
Kruppel-like factor 5 (intestinal) |
chr8_+_104892639 | 0.35 |
ENST00000436393.2 |
RIMS2 |
regulating synaptic membrane exocytosis 2 |
chr2_-_160472952 | 0.35 |
ENST00000541068.2 ENST00000355831.2 ENST00000343439.5 ENST00000392782.1 |
BAZ2B |
bromodomain adjacent to zinc finger domain, 2B |
chr11_-_34535297 | 0.35 |
ENST00000532417.1 |
ELF5 |
E74-like factor 5 (ets domain transcription factor) |
chr2_-_69180012 | 0.35 |
ENST00000481498.1 |
GKN2 |
gastrokine 2 |
chr20_+_52105495 | 0.35 |
ENST00000439873.2 |
AL354993.1 |
Cell growth-inhibiting protein 7; HCG1784586; Uncharacterized protein |
chr1_+_13910479 | 0.35 |
ENST00000509009.1 |
PDPN |
podoplanin |
chr10_-_123274693 | 0.35 |
ENST00000429361.1 |
FGFR2 |
fibroblast growth factor receptor 2 |
chr18_-_19994830 | 0.35 |
ENST00000525417.1 |
CTAGE1 |
cutaneous T-cell lymphoma-associated antigen 1 |
chr5_+_40841276 | 0.34 |
ENST00000254691.5 |
CARD6 |
caspase recruitment domain family, member 6 |
chr12_-_53320245 | 0.34 |
ENST00000552150.1 |
KRT8 |
keratin 8 |
chrX_+_105937068 | 0.34 |
ENST00000324342.3 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
chr4_+_77356248 | 0.34 |
ENST00000296043.6 |
SHROOM3 |
shroom family member 3 |
chr7_-_140340576 | 0.34 |
ENST00000275884.6 ENST00000475837.1 |
DENND2A |
DENN/MADD domain containing 2A |
chr8_-_134309823 | 0.34 |
ENST00000414097.2 |
NDRG1 |
N-myc downstream regulated 1 |
chr10_+_123923205 | 0.34 |
ENST00000369004.3 ENST00000260733.3 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr8_+_86121448 | 0.34 |
ENST00000520225.1 |
E2F5 |
E2F transcription factor 5, p130-binding |
chr5_+_140213815 | 0.34 |
ENST00000525929.1 ENST00000378125.3 |
PCDHA7 |
protocadherin alpha 7 |
chr11_+_27076764 | 0.34 |
ENST00000525090.1 |
BBOX1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr8_-_134309335 | 0.33 |
ENST00000522890.1 ENST00000323851.7 ENST00000518176.1 ENST00000354944.5 ENST00000537882.1 ENST00000522476.1 ENST00000518066.1 ENST00000521544.1 ENST00000518480.1 ENST00000523892.1 |
NDRG1 |
N-myc downstream regulated 1 |
chr14_-_21566731 | 0.33 |
ENST00000360947.3 |
ZNF219 |
zinc finger protein 219 |
chr22_+_32455111 | 0.33 |
ENST00000543737.1 |
SLC5A1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
chr10_-_52645379 | 0.33 |
ENST00000395489.2 |
A1CF |
APOBEC1 complementation factor |
chr4_-_110723134 | 0.33 |
ENST00000510800.1 ENST00000512148.1 |
CFI |
complement factor I |
chr12_-_71031220 | 0.33 |
ENST00000334414.6 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
chr1_-_202927490 | 0.33 |
ENST00000340990.5 |
ADIPOR1 |
adiponectin receptor 1 |
chr16_+_76587314 | 0.32 |
ENST00000563764.1 |
RP11-58C22.1 |
Uncharacterized protein |
chr2_-_26205340 | 0.32 |
ENST00000264712.3 |
KIF3C |
kinesin family member 3C |
chr14_-_21493884 | 0.32 |
ENST00000556974.1 ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2 |
NDRG family member 2 |
chr1_-_117210290 | 0.32 |
ENST00000369483.1 ENST00000369486.3 |
IGSF3 |
immunoglobulin superfamily, member 3 |
chrX_-_20236970 | 0.32 |
ENST00000379548.4 |
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
chr12_-_86650045 | 0.32 |
ENST00000604798.1 |
MGAT4C |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr8_-_95449155 | 0.32 |
ENST00000481490.2 |
FSBP |
fibrinogen silencer binding protein |
chr6_+_135502466 | 0.32 |
ENST00000367814.4 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr18_-_53177984 | 0.32 |
ENST00000543082.1 |
TCF4 |
transcription factor 4 |
chr11_+_12308447 | 0.32 |
ENST00000256186.2 |
MICALCL |
MICAL C-terminal like |
chr12_+_21207503 | 0.31 |
ENST00000545916.1 |
SLCO1B7 |
solute carrier organic anion transporter family, member 1B7 (non-functional) |
chr5_-_176836577 | 0.31 |
ENST00000253496.3 |
F12 |
coagulation factor XII (Hageman factor) |
chr11_-_119993979 | 0.31 |
ENST00000524816.3 ENST00000525327.1 |
TRIM29 |
tripartite motif containing 29 |
chr12_-_71031185 | 0.31 |
ENST00000548122.1 ENST00000551525.1 ENST00000550358.1 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
chr12_+_100867694 | 0.31 |
ENST00000392986.3 ENST00000549996.1 |
NR1H4 |
nuclear receptor subfamily 1, group H, member 4 |
chr1_+_15256230 | 0.31 |
ENST00000376028.4 ENST00000400798.2 |
KAZN |
kazrin, periplakin interacting protein |
chr9_-_23825956 | 0.30 |
ENST00000397312.2 |
ELAVL2 |
ELAV like neuron-specific RNA binding protein 2 |
chrX_-_117107680 | 0.30 |
ENST00000447671.2 ENST00000262820.3 |
KLHL13 |
kelch-like family member 13 |
chr1_+_86934526 | 0.30 |
ENST00000394711.1 |
CLCA1 |
chloride channel accessory 1 |
chr4_-_72649763 | 0.30 |
ENST00000513476.1 |
GC |
group-specific component (vitamin D binding protein) |
chr3_-_141868293 | 0.30 |
ENST00000317104.7 ENST00000494358.1 |
TFDP2 |
transcription factor Dp-2 (E2F dimerization partner 2) |
chr6_+_135502501 | 0.30 |
ENST00000527615.1 ENST00000420123.2 ENST00000525369.1 ENST00000528774.1 ENST00000534121.1 ENST00000534044.1 ENST00000533624.1 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
chr17_-_64225508 | 0.30 |
ENST00000205948.6 |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
chr1_+_77333117 | 0.30 |
ENST00000477717.1 |
ST6GALNAC5 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
chr11_+_6866883 | 0.30 |
ENST00000299454.4 ENST00000379831.2 |
OR10A5 |
olfactory receptor, family 10, subfamily A, member 5 |
chr9_-_88897426 | 0.29 |
ENST00000375991.4 ENST00000326094.4 |
ISCA1 |
iron-sulfur cluster assembly 1 |
chr7_-_37024665 | 0.29 |
ENST00000396040.2 |
ELMO1 |
engulfment and cell motility 1 |
chr11_-_117747607 | 0.29 |
ENST00000540359.1 ENST00000539526.1 |
FXYD6 |
FXYD domain containing ion transport regulator 6 |
chr7_-_16840820 | 0.29 |
ENST00000450569.1 |
AGR2 |
anterior gradient 2 |
chr10_+_82213904 | 0.29 |
ENST00000429989.3 |
TSPAN14 |
tetraspanin 14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.4 | 1.4 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.3 | 2.2 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.3 | 0.9 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.3 | 0.9 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.3 | 1.6 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.3 | 1.0 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.3 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.9 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.2 | 0.6 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 0.9 | GO:1902617 | response to fluoride(GO:1902617) |
0.2 | 1.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 1.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 3.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.8 | GO:0002159 | desmosome assembly(GO:0002159) endothelial cell-cell adhesion(GO:0071603) |
0.2 | 0.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 2.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.9 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 1.6 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 1.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.7 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 4.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.1 | 1.1 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.4 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.4 | GO:2001248 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.1 | 0.3 | GO:0035603 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
0.1 | 2.2 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.1 | 1.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.1 | 3.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 0.4 | GO:0060529 | squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
0.1 | 1.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.5 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.3 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.2 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.1 | 0.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.1 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.2 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.3 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.3 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.1 | 1.0 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 0.2 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.1 | 0.2 | GO:0043315 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.1 | 0.4 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.1 | 0.2 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 0.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.2 | GO:0060214 | endocardium formation(GO:0060214) |
0.1 | 0.2 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.2 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.1 | 0.2 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 0.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.2 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.1 | 0.4 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.4 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.1 | 0.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 2.5 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.4 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.0 | 0.2 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.0 | 0.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 0.2 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.0 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.0 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.0 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.2 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.0 | 0.2 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.4 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.2 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.0 | 0.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.0 | 0.0 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.0 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.5 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.2 | GO:0042335 | cuticle development(GO:0042335) |
0.0 | 0.6 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.0 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.3 | GO:0070778 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
0.0 | 0.1 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.0 | 0.0 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
0.0 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.1 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.2 | GO:0051025 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.2 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.3 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.0 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.1 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.0 | 0.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.2 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.0 | 0.2 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.1 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.0 | 0.1 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.0 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.1 | GO:0002786 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) |
0.0 | 0.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.0 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.2 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.0 | 0.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 0.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
0.0 | 0.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.0 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.1 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.0 | 0.0 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.0 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.1 | GO:0045659 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:1904387 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
0.0 | 0.0 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.0 | 0.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.2 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.0 | 0.8 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.0 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.1 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.0 | 0.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 2.7 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.0 | 4.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.1 | GO:0070631 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.0 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.0 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.1 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.1 | GO:0070837 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) dehydroascorbic acid transport(GO:0070837) response to Thyroglobulin triiodothyronine(GO:1904016) |
0.0 | 0.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.1 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.1 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.1 | GO:0061368 | negative regulation of growth hormone secretion(GO:0060125) behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.0 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.0 | 0.6 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.1 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.0 | 0.2 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.0 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.0 | 0.0 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.0 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.1 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.0 | 0.1 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.0 | 0.1 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.0 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.0 | GO:0070839 | divalent metal ion export(GO:0070839) |
0.0 | 0.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.0 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.0 | GO:0070640 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.1 | GO:0006552 | leucine metabolic process(GO:0006551) leucine catabolic process(GO:0006552) |
0.0 | 0.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.1 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.0 | 0.2 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 1.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.0 | 0.0 | GO:1903487 | regulation of lactation(GO:1903487) |
0.0 | 0.0 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
0.0 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.1 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.0 | 0.1 | GO:0043335 | protein unfolding(GO:0043335) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.0 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.0 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.0 | GO:0060460 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) superior vena cava morphogenesis(GO:0060578) |
0.0 | 0.0 | GO:0009111 | vitamin catabolic process(GO:0009111) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.4 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0060315 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.0 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.0 | 0.1 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.0 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.0 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.0 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.0 | 0.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.0 | 0.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.0 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.0 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 | 0.0 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.0 | 0.0 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.4 | 3.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 0.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 0.5 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 1.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.3 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.3 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.1 | 1.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 2.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.8 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 0.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.2 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 1.0 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 1.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.1 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 0.7 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.0 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 2.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.1 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.0 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.1 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.0 | 0.0 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 1.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 1.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 3.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 1.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.0 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 0.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.0 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.0 | 0.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 0.8 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.3 | 3.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 2.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 1.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 2.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.6 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 1.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.4 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 3.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.4 | GO:0008184 | purine nucleobase binding(GO:0002060) glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.3 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.1 | 0.5 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.1 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.8 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 0.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 0.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.1 | 0.4 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 1.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.3 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 1.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.3 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.3 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.1 | 0.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 0.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.0 | 0.3 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.0 | 0.1 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.0 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.0 | 0.2 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.0 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 1.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.0 | 1.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.0 | 0.4 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.1 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.0 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.2 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.3 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.1 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.0 | 0.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 2.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.1 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.0 | 0.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.0 | 0.2 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.0 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.1 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.0 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:1903135 | cupric ion binding(GO:1903135) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 0.7 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.0 | 1.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.6 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 4.3 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.0 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.0 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.0 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.0 | 1.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 0.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.2 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.0 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.0 | 0.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.0 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0017153 | citrate transmembrane transporter activity(GO:0015137) succinate transmembrane transporter activity(GO:0015141) tricarboxylic acid transmembrane transporter activity(GO:0015142) sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.0 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.0 | 0.0 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.0 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.0 | 0.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 3.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 1.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 2.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 2.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.2 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 2.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.6 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 2.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 1.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 3.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 2.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 1.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |